Evidence map›Paper›PMID 40924724›Full record

ArticlePloS one2025

Predicting mortality dynamics in cancer patients: A machine learning approach to pre-death events.

Tatsuki Yamamoto, Minoru Sakuragi, Yuzuha Tuji, Yuji Okamoto, Eiichiro Uchino, Motoko Yanagita, Manabu Muto, Mayumi Kamada, Yasushi Okuno

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tatsuki YamamotoDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Minoru SakuragiDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuzuha TujiDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yuji OkamotoDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Eiichiro UchinoDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Motoko YanagitaDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Manabu MutoDepartment of Clinical Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Mayumi KamadaDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yasushi OkunoDepartment of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-3596-4208

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capturing the dynamic changes in patients' internal states as they approach death due to fatal diseases remains a major challenge in understanding individual pathologies and improving end-of-life care. However, existing methods primarily focus on specific test values or organ dysfunction markers, failing to provide a comprehensive view of the evolving internal state preceding death. To address this, we analyzed electronic health record (EHR) data from a single institution, including 8,976 cancer patients and 77 laboratory parameters, by constructing continuous mortality prediction models based on gradient-boosting decision trees and leveraging them for temporal analyses. We applied Shapley Additive exPlanations (SHAP) to assess the contribution of individual features over time and employed a SHAP-based clustering approach to classify patients into distinct subtypes based on mortality-related feature dynamics. Our analysis identified three distinct clinical patterns in patients near death, with key laboratory parameters-including albumin, C-reactive protein, blood urea nitrogen, and lactate dehydrogenase-playing a critical role. Dimensionality reduction techniques demonstrated that SHAP-based patient stratification effectively captured hidden variations in terminal disease progression, whereas traditional stratification using raw laboratory values failed to do so. These findings suggest that machine learning-driven temporal analysis can reveal clinically meaningful state transitions that conventional approaches overlook, offering new insights into the heterogeneous nature of terminal disease progression. This framework has the potential to enhance personalized risk stratification and optimize individualized end-of-life care strategies by identifying distinct patient trajectories that may inform more targeted interventions.

Indexed as

Machine LearningNeoplasmsAgedDisease ProgressionElectronic Health RecordsFemaleHumansMaleMiddle AgedPrognosisTerminal Care

Identifiers

PMID40924724
PMCPMC12419616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.